BioNeutra International, Ltd.
BIMO · OTC
4/30/2023 | 1/31/2023 | 10/31/2022 | 7/31/2022 | |
|---|---|---|---|---|
| Revenue | $25 | $21 | $0 | $0 |
| % Growth | 18.4% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $25 | $21 | $0 | $0 |
| % Margin | 99.5% | 99.4% | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $20 | $33 | $23 | $19 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $20 | $33 | $23 | $19 |
| Operating Income | $5 | -$12 | -$23 | -$19 |
| % Margin | 20.3% | -58.7% | – | – |
| Other Income/Exp. Net | -$6 | -$18 | -$3 | -$7 |
| Pre-Tax Income | -$1 | -$19 | -$30 | -$26 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$19 | -$30 | -$26 |
| % Margin | -5.7% | -89.5% | – | – |
| EPS | -0 | -0 | -0 | -0 |
| % Growth | 91.4% | 50% | 0% | – |
| EPS Diluted | -0 | -0 | -0 | -0 |
| Weighted Avg Shares Out | 163,430 | 163,430 | 163,430 | 163,430 |
| Weighted Avg Shares Out Dil | 163,430 | 163,430 | 163,430 | 163,430 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $6 | $6 | $7 | $7 |
| Depreciation & Amortization | $0 | $0 | $27 | $86 |
| EBITDA | -$12 | -$23 | -$23 | -$19 |
| % Margin | -49.1% | -111.6% | – | – |